Hypertrophy, Left Ventricular
Recent clinical, regulatory, research and industry developments relating to this disease.
Subclinical Primary Aldosteronism and Cardiovascular Health: A Population-Based Cohort Study.
Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies.
Recommendations for the evaluation of left ventricular diastolic function by echocardiography.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes7
- Heart Failure2
- Cardiology1
- Cardiomyopathies1
- Cardiovascular Diseases1
- Hyperaldosteronism1
- Hypertension1
- Ventricular Function, Left1
Leading journals4
- European journal of heart failure2
- Cardiovascular research1
- Circulation1
- European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology1
Leading researchers8
- Bayes-Genis A2
- de Boer RA2
- Metra M2
- Moura B2
- Rosano G2
- Savarese G2
- Abdelhamid M1
- Adamo M1
Affiliations (unnormalised)6
- Brigham and Women's Hospital2
- Karolinska Institutet2
- Karolinska University Hospital2
- Serbian Academy of Sciences and Arts2
- University of Brescia2
- American University of Beirut Medical Center1
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Disease profile
A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.
Left ventricular hypertrophy is enlargement of the left ventricle of the heart. It reflects an increase in ventricular mass and is associated with cardiovascular morbidity and mortality. The supplied grounding describes it as a response to sustained abnormal pressure or volume load.
It is attributed to sustained abnormal pressure or volume loads on the left ventricle. The grounding does not support a more specific aetiology beyond this hemodynamic loading.
The core biological change is increased left ventricular mass, with associated alteration in left ventricular function. The supplied material links the condition to sustained abnormal pressure or volume loading, but does not provide additional mechanistic detail.
Sustained abnormal pressure or volume load is the supported risk factor in the supplied grounding. No other specific risk factors are supported by the provided material.
AI-generated summary grounded in MeSH and 1 peer-reviewed source. Informational only — not medical advice. Generated 2026-07-07.
Reference
Authoritative identity, definition & identifiers.
Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.